The dose‐limiting toxicity of Vorinostat was thrombocytopenia, which caused a transient reduction and pause (patient CALD1, Fig. 5D) or permanent withdrawal (patients CALD2 and CALD3, Fig. 5E and F) of Vorinostat. Here, CALD1 is linked to Thrombocytopenia.